KDM6B and neoplasm: In certain cancer types, such as neuroblastoma, hepatocellular carcinoma, lung adenocarcinoma, and endometrial cancer, KDM6B functions as a tumor suppressor, and its expression is associated with improved survival rates and prognoses (138–141).